Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
20.47
-0.12 (-0.58%)
At close: Nov 2, 2026, 4:00 PM EST
20.25
-0.22 (-1.08%)
After-hours: Nov 2, 2026, 7:39 PM EST
Acadia Pharmaceuticals Market Cap
Acadia Pharmaceuticals has a market cap or net worth of $3.53 billion as of November 2, 2026. It is the 4,557th most valuable company in the world and the 1,396th biggest in the United States. Its market cap has decreased by 7.90% in one year.
Market Cap
3.53B
Enterprise Value
2.64B
1-Year Change
-7.90%
Global Rank
Country Rank
#1,396 United States
Category
ChartMarket Cap Chart
Since May 27, 2004, Acadia Pharmaceuticals's market cap has increased from $112.80M to $3.53B, an increase of 3,026.86%. That is a compound annual growth rate of 16.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 3.53B | -21.95% |
| Dec 31, 2025 | 4.52B | 48.00% |
| Dec 31, 2024 | 3.05B | -40.60% |
| Dec 29, 2023 | 5.14B | 99.41% |
| Dec 30, 2022 | 2.58B | -31.29% |
| Dec 31, 2021 | 3.75B | -55.85% |
| Dec 31, 2020 | 8.50B | 28.98% |
| Dec 31, 2019 | 6.59B | 225.79% |
| Dec 31, 2018 | 2.02B | -45.92% |
| Dec 29, 2017 | 3.74B | 7.07% |
| Dec 30, 2016 | 3.49B | -2.91% |
| Dec 31, 2015 | 3.60B | 13.57% |
| Dec 31, 2014 | 3.17B | 39.50% |
| Dec 31, 2013 | 2.27B | 762.44% |
| Dec 31, 2012 | 263.30M | 361.93% |
| Dec 30, 2011 | 57.00M | 20.76% |
| Dec 31, 2010 | 47.20M | -6.53% |
| Dec 31, 2009 | 50.50M | 51.20% |
| Dec 31, 2008 | 33.40M | -91.84% |
| Dec 31, 2007 | 409.20M | 56.24% |
| Dec 29, 2006 | 261.90M | 13.18% |
| Dec 30, 2005 | 231.40M | 102.63% |
| Dec 31, 2004 | 114.20M | 1.24% |
| May 27, 2004 | 112.80M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 3.98B |
| Iovance Biotherapeutics | 3.84B |
| Tango Therapeutics | 3.83B |
| Xenon Pharmaceuticals | 3.62B |
| Disc Medicine | 3.59B |
| Parabilis Medicines | 3.50B |
| Viking Therapeutics | 3.48B |
| Celcuity | 3.38B |